NGC® – Scientifically Proven, Clinically Backed

Core Research Areas & Clinical Benefits

Glycemic Load & Blood Sugar Control

  • Stabilizes post-meal glucose response
  • Reduces insulin spikes and improves metabolic flexibility

Weight Management & Satiety

  • Supports gradual, sustainable weight loss
  • Reduces hunger signals and food cravings
  • Naturally slows gastric emptying for longer-lasting satiety

Metabolic Syndrome & Diabetes Support

  • Tested in patients with type 2 diabetes and gestational diabetes (GDM)
  • Helps lower blood lipids and inflammatory markers
  • Contributes to improved metabolic profiles

Cognitive Performance

  • Clinical results show improved focus and mental clarity, particularly in school-aged children

Type 2 Diabetes

12-week daily use drives broad metabolic improvement

Key findings

  • 43% of patients lost more than 3% of body weight over 12 weeks
  • Higher satiety reported versus habitual breakfast
  • CRP drop of 53% signals significant reduction in systemic inflammation
  • HbA1c improvement of 5.4% exceeds typical dietary-intervention benchmarks
  • Zero adverse effects reported across the 12-week trial

Cognition in Children

Measurable gains in focus, calm, and school performance

Key findings

  • Statistically significant gains on reading and mathematics tests
  • Teachers reported calmer, more focused classrooms
  • Mid-morning hunger fell by 43%, smoothing energy through the school day
  • Effects reversed when NGC was stopped — confirming a causal link
  • Crossover design controls for placebo and seasonal effects

2-Year Obesity Program

Sustained Weight Loss

KEY FINDINGS

  • Unique result: weight loss continued into year 2 (no rebound)
  • Average 13.6 kg weight loss sustained through 24 months
  • CRP inflammation marker reduced significantly
  • LDL/HDL and ApoB/ApoA1 both declined to cardiovascular-safe ranges
  • Insulin fell 30% within 3 months and held through the program
  • 100% of participants reported improved energy and wellbeing
  • Insulin normalised within 3 months of program start

Gl

Glycemic Index in Japanese Adults

Key findings

  • IZP100% significantly reduced blood glucose AUC vs rice
  • GI of 30.8 classified as low-GI internationally
  • Partial replacement (IZP20%) also lowered the glucose trend
  • No adverse events reported
  • Confirms InZone/NGC suitable for Asian dietary patterns

Proven Results, Real Impact

NGC® is not just science—it’s practical, real-world functionality. Used in both healthy individuals and clinical populations, results show measurable and repeatable outcomes, including improved glycemic control, reduced cravings, and better performance in weight management and diabetes prevention programs.

Backed by decades of expertise, global patents, and peer-reviewed research, NGC® is your go-to ingredient for functional, natural, and effective nutrition solutions.

University of Sydney
Tianjin Medical University
Lund univ
Peking university people's hospital
leatherhead food research